Celularity (CELUW) EBITDA Margin (2020 - 2025)
Celularity (CELUW) reported EBITDA Margin of 593.62% for Q4 2025, up 133894.0% year-over-year from N/an in Q4 2024, and down 35.95% quarter-over-quarter from 436.66% in Q3 2025.
Celularity (CELUW) EBITDA Margin (2020 - 2025) Analysis & Trends
Celularity (CELUW) has 6 years of EBITDA Margin data on file, last reported at 593.62% in Q4 2025.
- EBITDA Margin for Q4 2025 came in at 593.62%, up 133894.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 345.43% (down 18800.0% YoY), and the FY2025 annual result was 345.43%, down 23865.0% from the prior year.
- EBITDA Margin retreated to 593.62% in Q4 2025 per CELUW's latest filing, from 436.66% in the prior quarter.
- Over five years, EBITDA Margin peaked at 1266.58% in Q2 2022 and troughed at 2479.56% in Q3 2023.
- A 5-year average of 591.18% and a median of 300.4% in 2025 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin surged 316245 bps in 2022, then slumped 290776 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 83.2% in 2021, then surged by 805 bps to 586.27% in 2022, then plunged by 90 bps to 59.05% in 2023, then plunged by 3373 bps to 1932.56% in 2024, then surged by 69 bps to 593.62% in 2025.
- Business Quant data shows CELUW's EBITDA Margin at 593.62% in Q4 2025, 436.66% in Q3 2025, and 427.6% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Celularity | - | - | -3.27 Mn | -593.62% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -593.62% |
| Sep 30, 2025 | -436.66% |
| Jun 30, 2025 | -427.60% |
| Mar 31, 2025 | -172.84% |
| Dec 31, 2024 | -1,932.56% |
| Sep 30, 2024 | -173.19% |
| Jun 30, 2024 | -53.57% |
| Mar 31, 2024 | -149.94% |
| Dec 31, 2023 | 59.05% |
| Sep 30, 2023 | -2,479.56% |
| Jun 30, 2023 | -1,641.18% |
| Mar 31, 2023 | -1,559.31% |
| Dec 31, 2022 | 586.27% |
| Sep 30, 2022 | 121.77% |
| Jun 30, 2022 | 1,266.58% |
| Mar 31, 2022 | -1,059.26% |
| Dec 31, 2021 | -83.20% |
| Sep 30, 2021 | 470.14% |
| Jun 30, 2021 | -1,895.87% |
| Mar 31, 2021 | -1,668.98% |